Contra-indicated in patients with diabetes.
- TRADE NAMES: Benicar (Sankyo); Olmetec (Daiichi Sankyo)
- INDICATIONS: Hypertension
- CLASS: Angiotensin receptor antagonist (blocker), Antihypertensive
- HALF-LIFE: ~13 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Adrenergic neurone blockers, Aldesleukin, Aliskiren, Alprostadil, Amifostine, Antihypertensives, Antipsychotics, Anxiolytics and hypnotics, Baclofen, Beta blockers, Calcium channel blockers, Clonidine, Colesevelam, Corticosteroids, Cyclosporine, Diazoxide, Diuretics, Eltrombopag, Eplerenone, Estrogens, General anesthetics, Heparins, Hydralazine, Levodopa, Lithium, MAO inhibitors, Methyldopa, Methylphenidate, Minoxidil, Moxisylyte, Moxonidine, Nitrates, Nitroprusside, NSAIDs, Pentoxifylline, Phosphodiesterase 5 inhibitors, Potassium salts, Quinine, Rituximab, Tacrolimus, Tizanidine, Tolvaptan, Trimethoprim - PREGNANCY: category C in first trimester; category D in second and third trimesters
- See adverse reactions attributed to class:
FETAL TOXICITY
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 03/26/2024
